Literature DB >> 27306630

Comment: Methotrexate for patients with generalized myasthenia gravis.

Daniel B Drachman1.   

Abstract

Entities:  

Year:  2016        PMID： 27306630     DOI： 10.1212/WNL.0000000000002818

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  2 in total

Review 1.  Immunotherapy in myasthenia gravis in the era of biologics.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

2.  A Randomized Open-Labeled Trial of Methotrexate as a Steroid-Sparing Agent for Patients With Generalized Myasthenia Gravis.

Authors:  Li Di; Faxiu Shen; Xinmei Wen; Yan Lu; Wenjia Zhu; Min Wang; Yuwei Da
Journal:  Front Immunol       Date:  2022-03-18       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.